- $67.15m
- $71.10m
- $46.09m
- 94
- 70
- 56
- 86
2019 June 30th | 2020 June 30th | R2021 June 30th | R2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 27.2 | 34.8 | 38 | 42 | 46.1 |
Cost of Revenue | |||||
Gross Profit | 9.78 | 13.1 | 13.6 | 13.1 | 12.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 22.2 | 27.8 | 33.5 | 36.9 | 40.3 |
Operating Profit | 5 | 7.07 | 4.53 | 5.12 | 5.76 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.45 | 7.9 | 7.62 | 5.69 | 9.43 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.14 | 6.11 | 6.17 | 4.57 | 7.07 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4.15 | 6.11 | 6.17 | 4.57 | 7.07 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.15 | 6.11 | 6.17 | 4.57 | 7.07 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.962 | 1.5 | 1.57 | 1.22 | 1.95 |